ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,704, issued on April 14, was assigned to STINGINN LLC (Miami).
"Substituted 1,2,4-triazoles and methods of use" was invented by Glen N Barber (Miami).
According to the abstract* released by the U.S. Patent & Trademark Office: "In an embodiment of the present invention, compounds of the present application or pharmaceutically acceptable salts thereof are capable of interacting with and activating the stimulator of interferon genes (STING) protein. In an embodiment of the present invention, pharmaceutical compositions and methods involving such compounds as STING modulators are additionally provided herein."
The patent was filed on March 28, 2024, under Application No. 18/620,876...